Keywords: pharmacopeia, gets, 5m, milestone, gsk, small-molecule, specialist
Pharmacopeia gets $5M milestone from GSK
Article | 18 June 2007
US small-molecule specialist drugmaker Pharmacopeia has received a $5.0 million milestone from UK drug major GlaxoSmithKline as part of their R& ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
